Novel therapies to augment neurological benefits of cellular therapies for traumatic spinal cord injury
Novel therapies to augment neurological benefits of cellular therapies for traumatic spinal cord injury
批准号:
369844
负责人:
Karimi-Abdolrezaee Soheila
金额:
$77.19万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-09-01 至 2022-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Spinal cord injury (SCI) is a leading cause of permanent neurological disabilities affecting over 2.5 million individuals worldwide. In Canada, there are over 86,000 patients who are afflicted with lifelong consequences of SCI with approximately 4,200 new
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Harnessing the potential of CNS progenitor cells for repairing progressive multiple sclerosis.
-
批准号:488468
-
项目类别:Operating Grants
-
资助金额:$83.32万
-
财政年份:2023
-
负责人:Karimi-Abdolrezaee Soheila
-
依托单位:
Evaluating novel approaches to promote neuroregeneration and functional recovery after spinal cord injury
-
批准号:469253
-
项目类别:Operating Grants
-
资助金额:$82.76万
-
财政年份:2022
-
负责人:Karimi-Abdolrezaee Soheila
-
依托单位:
Neuroregenerative approaches to enhance white matter repair and functional recovery following traumatic spinal cord injury: reconditioning the injured microenvironment
-
批准号:293451
-
项目类别:Operating Grants
-
资助金额:$51.41万
-
财政年份:2013
-
负责人:Karimi-Abdolrezaee Soheila
-
依托单位: